Brightflow SAS develops minimally invasive cardiac medical devices for treating end-stage heart failure.

Antabio is a French biopharmaceutical company developing novel treatments for drug-resistant bacterial infections, with a focus on life-threatening respiratory conditions and a portfolio that includes a metallo beta-lactamase inhibitor.

Poppins develops digital therapeutic musical video games for children with neurodevelopmental disorders, such as dyslexia and dyscalculia, and has raised €8 million in funding to expand their program and support further research.